Search Results for: Diabetes

3097 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
CDKN2A and HNRNPC cyclin-dependent kinase inhibitor 2A heterogeneous nuclear ribonucleoprotein C (C1/C2)
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Splicing
  • mRNA Splicing - Major Pathway
CDKN2A and RUVBL2 cyclin-dependent kinase inhibitor 2A RuvB-like AAA ATPase 2
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • Chromatin modifying enzymes
  • Telomere Maintenance
  • Chromosome Maintenance
  • Chromatin organization
  • Extension of Telomeres
  • Telomere Extension By Telomerase
  • HATs acetylate histones
CDKN2A and HNRNPU cyclin-dependent kinase inhibitor 2A heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Splicing
  • mRNA Splicing - Major Pathway
CDKN2A and GGA3 cyclin-dependent kinase inhibitor 2A golgi-associated, gamma adaptin ear containing, ARF binding protein 3
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
CDKN2A and CDC7 cyclin-dependent kinase inhibitor 2A cell division cycle 7
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • G1/S Transition
  • G2/M Checkpoints
  • Activation of ATR in response to replication stress
  • Activation of the pre-replicative complex
  • DNA Replication Pre-Initiation
  • M/G1 Transition
  • Cell Cycle Checkpoints
  • Activation of the pre-replicative complex
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
CDKN2A and CDC45 cyclin-dependent kinase inhibitor 2A cell division cycle 45
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • E2F mediated regulation of DNA replication
  • Synthesis of DNA
  • G2/M Checkpoints
  • Activation of the pre-replicative complex
  • DNA Replication Pre-Initiation
  • M/G1 Transition
  • Activation of the pre-replicative complex
  • S Phase
  • DNA strand elongation
  • Cell Cycle, Mitotic
  • Activation of ATR in response to replication stress
  • G1/S Transition
  • G1/S-Specific Transcription
  • Cell Cycle Checkpoints
  • Mitotic G1-G1/S phases
  • Unwinding of DNA
CDKN2A and TUBB4B cyclin-dependent kinase inhibitor 2A tubulin, beta 4B class IVb
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • Transport of connexons to the plasma membrane
  • Hedgehog 'off' state
  • Formation of tubulin folding intermediates by CCT/TriC
  • Regulation of PLK1 Activity at G2/M Transition
  • Prefoldin mediated transfer of substrate to CCT/TriC
  • Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding
  • Gap junction trafficking and regulation
  • Recruitment of mitotic centrosome proteins and complexes
  • Orphan transporters
  • Gap junction assembly
  • Gap junction trafficking
  • Factors involved in megakaryocyte development and platelet production
  • Resolution of Sister Chromatid Cohesion
  • Mitotic G2-G2/M phases
  • Mitotic Metaphase and Anaphase
  • Adaptive Immune System
  • Mitotic Prometaphase
  • Organelle biogenesis and maintenance
  • Axon guidance
  • Separation of Sister Chromatids
  • Translocation of GLUT4 to the plasma membrane
  • G2/M Transition
  • L1CAM interactions
  • Mitotic Anaphase
  • Recycling pathway of L1
  • Recruitment of NuMA to mitotic centrosomes
  • M Phase
  • Intraflagellar transport
  • Post-chaperonin tubulin folding pathway
  • Loss of Nlp from mitotic centrosomes
  • MHC class II antigen presentation
  • Protein folding
  • Kinesins
  • Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
  • Assembly of the primary cilium
  • Anchoring of the basal body to the plasma membrane
  • Cell Cycle, Mitotic
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Signaling by Hedgehog
  • Chaperonin-mediated protein folding
  • Centrosome maturation
  • Albendazole
  • Mebendazole
  • Epothilone D
  • Epothilone B
CDKN2A and UBE2A cyclin-dependent kinase inhibitor 2A ubiquitin-conjugating enzyme E2A
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Class I MHC mediated antigen processing & presentation
  • Adaptive Immune System
CDKN2A and TUBA1A cyclin-dependent kinase inhibitor 2A tubulin, alpha 1a
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • Transport of connexons to the plasma membrane
  • Mitotic Prometaphase
  • Organelle biogenesis and maintenance
  • Axon guidance
  • Hedgehog 'off' state
  • Separation of Sister Chromatids
  • Translocation of GLUT4 to the plasma membrane
  • L1CAM interactions
  • G2/M Transition
  • Mitotic Anaphase
  • Recycling pathway of L1
  • Recruitment of NuMA to mitotic centrosomes
  • Regulation of PLK1 Activity at G2/M Transition
  • Formation of tubulin folding intermediates by CCT/TriC
  • Intraflagellar transport
  • M Phase
  • Prefoldin mediated transfer of substrate to CCT/TriC
  • Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding
  • Post-chaperonin tubulin folding pathway
  • Loss of Nlp from mitotic centrosomes
  • Gap junction trafficking and regulation
  • MHC class II antigen presentation
  • Recruitment of mitotic centrosome proteins and complexes
  • Protein folding
  • Gap junction assembly
  • Gap junction trafficking
  • Kinesins
  • Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
  • Assembly of the primary cilium
  • Factors involved in megakaryocyte development and platelet production
  • Anchoring of the basal body to the plasma membrane
  • Cell Cycle, Mitotic
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Resolution of Sister Chromatid Cohesion
  • Chaperonin-mediated protein folding
  • Signaling by Hedgehog
  • Centrosome maturation
  • Mitotic G2-G2/M phases
  • Mitotic Metaphase and Anaphase
  • Adaptive Immune System
  • Albendazole
  • Vinblastine
  • Mebendazole
  • Epothilone D
  • Epothilone B
  • 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE
CDKN2A and GAPDH cyclin-dependent kinase inhibitor 2A glyceraldehyde-3-phosphate dehydrogenase
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • Gluconeogenesis
  • Glucose metabolism
  • Myoclonic epilepsy of Lafora
  • Glycogen storage diseases
  • Glycolysis
  • Metabolism of carbohydrates
  • NADH
  • Nicotinamide-Adenine-Dinucleotide
  • Adenosine-5-Diphosphoribose
  • Thionicotinamide-Adenine-Dinucleotide
  • 4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE
CDKN2A and AHNAK cyclin-dependent kinase inhibitor 2A AHNAK nucleoprotein
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
CDKN2A and RIN2 cyclin-dependent kinase inhibitor 2A Ras and Rab interactor 2
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
CDKN2A and PEX19 cyclin-dependent kinase inhibitor 2A peroxisomal biogenesis factor 19
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • ABC-family proteins mediated transport
  • ABCA transporters in lipid homeostasis
CDKN2A and PPP1R9B cyclin-dependent kinase inhibitor 2A protein phosphatase 1, regulatory subunit 9B
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
CDKN2A and ANKRD12 cyclin-dependent kinase inhibitor 2A ankyrin repeat domain 12
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
CDKN2A and UBE4B cyclin-dependent kinase inhibitor 2A ubiquitination factor E4B
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
CDKN2A and HSPA4 cyclin-dependent kinase inhibitor 2A heat shock 70kDa protein 4
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
CDKN2A and HSPA8 cyclin-dependent kinase inhibitor 2A heat shock 70kDa protein 8
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Splicing
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • Axon guidance
  • Golgi Associated Vesicle Biogenesis
  • Attenuation phase
  • mRNA Splicing - Major Pathway
  • L1CAM interactions
  • Regulation of HSF1-mediated heat shock response
  • Cellular response to heat stress
  • AUF1 (hnRNP D0) destabilizes mRNA
  • GABA synthesis, release, reuptake and degradation
  • Clathrin derived vesicle budding
  • Lysosome Vesicle Biogenesis
  • HSF1-dependent transactivation
  • Neurotransmitter Release Cycle
  • CHL1 interactions
  • trans-Golgi Network Vesicle Budding
  • Transmission across Chemical Synapses
CDKN2A and PLEKHA8 cyclin-dependent kinase inhibitor 2A pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
CDKN2A and HSP90AA1 cyclin-dependent kinase inhibitor 2A heat shock protein 90kDa alpha (cytosolic), class A member 1
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • HSF1 activation
  • Regulatory RNA pathways
  • Signaling by EGFRvIII in Cancer
  • Regulation of PLK1 Activity at G2/M Transition
  • Influenza Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Uptake and actions of bacterial toxins
  • EPH-Ephrin signaling
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Recruitment of mitotic centrosome proteins and complexes
  • Regulation of actin dynamics for phagocytic cup formation
  • vRNP Assembly
  • Influenza Infection
  • Signaling by ERBB2
  • Signaling by VEGF
  • Signaling by EGFR in Cancer
  • Sema3A PAK dependent Axon repulsion
  • Mitotic G2-G2/M phases
  • Uptake and function of diphtheria toxin
  • PIWI-interacting RNA (piRNA) biogenesis
  • Organelle biogenesis and maintenance
  • Axon guidance
  • Attenuation phase
  • G2/M Transition
  • VEGFA-VEGFR2 Pathway
  • HSF1-dependent transactivation
  • EPHA-mediated growth cone collapse
  • Metabolism of nitric oxide
  • VEGFR2 mediated vascular permeability
  • Loss of Nlp from mitotic centrosomes
  • Scavenging by Class F Receptors
  • eNOS activation and regulation
  • Innate Immune System
  • Semaphorin interactions
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Assembly of the primary cilium
  • Cellular response to heat stress
  • Anchoring of the basal body to the plasma membrane
  • Cell Cycle, Mitotic
  • eNOS activation
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Centrosome maturation
  • Constitutive Signaling by EGFRvIII
  • Rifabutin
  • Nedocromil
  • 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine
  • Geldanamycin
  • 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
  • 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine
  • 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid
  • 17-Dmag
  • 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
  • 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine
  • Adenosine-5\'-Diphosphate
  • 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
  • 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole
  • 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine
  • 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine
  • 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
  • 8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine
  • 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
  • N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
  • N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
  • 4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE
  • 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE
  • 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide
  • 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
  • (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one
  • 6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE
  • 3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE
  • N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE
  • 4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol
  • 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL
  • 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol
  • 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE
  • 4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine
  • (5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime
  • 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-
  • 4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol
  • 2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol
  • 2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide
  • 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine
  • 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine
  • 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE
  • 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE

Page 6 out of 155 pages